This rulemaking is being provided to the Council for review and approval as a final rulemaking. It allows medical cannabis businesses licensed under the District’s Medical Cannabis Program to remediate medical cannabis and medical cannabis products that fail testing for reasons that may be addressed without harm to patients.

These amendments would bring the District in line with other market basket states that allow remediation of products that fail testing under certain circumstances, and will also reduce waste by licensed businesses, as allowing remediation will allow for the repurposing of useable product that would otherwise be destroyed. 

Upon approval by the Council, this rulemaking will be submitted to the D.C. Register for publication and incorporation into the regulations.